Bio-Rad Laboratories

BIO-RAD LABORATORIES-A

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

NYSE

$BTC

$XRP

COIN

SPDR Dow Jones Industrial Average ETF Trust

DKNG

DXCM

FROG

MRNA

NVDA

PANW

PCOR

ROKU

SERV

SOUN

iShares Trust Barclays 20+ Year Treasury Bond Fund

UDMY

WYNN

Select Sector SPDR-Consumer Discretionary

Stocks are headed for weekly gains, with the Dow Jones dipping slightly and the S&amp;P 500 and Nasdaq trading just above the flatline Friday.

Stocks Head For Weekly Gains, US Treasury Yields Fall Below 4.5%: What&#39;s Driving Markets Friday?

Large Cap

Mid Cap

News

Offerings

Contracts

Travel

Markets

Analyst Ratings

Tech

Trading Ideas

Insurance

General

DELL

ERIE

ETSY

PLTR

The S&amp;P 500 is a widely recognized benchmark for the US stock market, and it has undergone reshuffling due to the quarterly rebalancing process. This shake-up, driven by shifts in company performance and market capitalization, provides a unique lens into the evolving dynamics of the business world. The inclusion of several companies reflects a changing market terrain.

S&amp;P 500 Shake-Up: New Entrants Driving Market Momentum


The S&amp;P 500 is a widely recognized benchmark for the US stock market, and it has undergone reshuffling due to the quarterly rebalancing process. This shake-up, driven by shifts in company performance and market

Bio-Rad Laboratories, Inc. Class A Common Stock

Bio-Rad Laboratories Inc

Bio-Rad Laboratories, Inc. Class B Common Stock

Bioage Labs Inc

BIOASIS TECHNOLOGIES INC by Bioasis Technologies Inc.

Bioasis Technologies Inc

Biocept Inc COM PAR $0.0001 NEW 2023

Biocept Inc

Bio Essence Corp

Blue Biofuels Inc

BIOCARTIS GROUP NV by BIOCARTIS GROUP NV

BioGaia AB

Biome Grow Inc

Biolase Inc COM PAR $.001 NEW

Biolase Inc

BIONITROGEN HLDGS CORP by BioNitrogen Holdings Corp.

BioNitrogen Holdings Corp

Bioqual Inc

Biora Therapeutics Inc

BIORA THERAPEUTCS INC by Biora Therapeutics, Inc.

BioPassport Token

SWEDISH ORPHAN BIOVIT ORD by Swedish Orphan Biovitrum AB

Swedish Orphan Biovitrum AB

Bioceres Crop Solutions Corp. - Ordinary Shares

Bioceres Crop Solutions Corp

Biosyent Inc

Press Releases

Oncocyte Prices $29.1 Million Equity Offering

Bio-Rad Offers to Acquire Digital PCR Developer Stilla Technologies

Bio-Rad Reports Fourth-Quarter and Full-Year 2024 Financial Results

Mutual Funds

Alger Russell Innovation Index Updates for First Quarter 2025

Earnings

Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts

Bio-Rad to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025

Health Care

Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types

Bio-Rad Reports First-Quarter 2025 Financial Results

Bio-Rad's Management to Participate in Fireside Chat During 2025 RBC Capital Markets Global Healthcare Conference

Bio-Rad's Management to Host Investor Meetings During Jefferies Global Healthcare Conference

BDSX

JNPR

NTNX

PYPL

RBLX

SOLV

Agilent Technologies

AbCellera Biologics

Adaptive Biotechnologies Corporation - Common Stock

Adaptive Biotechnologies

Avantor

Azenta

BioLife Solutions

Bruker

Charles River Laboratories International, Inc. Common Stock

Charles River

Danaher

Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share

Comments

Bio-Rad Laboratories

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell